By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Supreme Court today invalidated two patents held by Prometheus Laboratories in a widely watched case for those involved in the personalized medicine field.

In a unanimous decision, the court called the patents in dispute, US Patent Nos. 6,355,623 and 6,680,302 unpatentable because they merely describe the laws of nature and "add nothing specific to the laws of nature other than what is well-understood, routine, conventional activity."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.